保險股全面回吐 太保及中國太平跌4%-5%
投資者重新權衡疫苗研發露曙光及經濟反彈的可能時機,資金再次由舊經濟股轉投科技股,本港除銀行及地產股顯著回吐外,保險股也難獨善其身,尤其是中國太平(00966.HK)扭五連升,最低見12.4元(剛為10天線),現造12.66元,回吐5.1%,成交達1,934萬股,已接近昨天全日成交量。太保(02601.HK)扭五連漲,股價由逾八個月高位回落,最低見26.8元,現造27元,回吐3.9%。
新華保險(01336.HK)、中國再保險(01508.HK)、人保(01339.HK)及財險(02328.HK)回吐逾1%-2%,後者沽壓最大,低見5.88元,現造5.91元,回吐2.1%;國壽(02628.HK)重失牛熊線及百天線(18.1元及18.2元),最低見17.74元,現造17.92元,跌1.5%。
國際保險股以友邦(01299.HK)沽壓較大,該股繼昨天升至90元創紀錄高遇阻打回原形後,今天低見83.35元,現造83.8元,回吐3.6%。保誠(02378.HK)回吐2.2%曾低見125元;宏利(00945.HK)曾考驗牛熊線(123.2元),最低見123元,現造126元,回吐2%。
恆指現造26,130,反覆續吐96點,成交額1,229億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.